Humacyte, Inc. (HUMA) Total liabilities 2024–2025
Humacyte, Inc. (HUMA) total liabilities at each fiscal year-end, per SEC filings.
$113.3MFY2025 · since FY2024: $190.5M → $113.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $113.3M | -40.6% |
| FY2024 | $190.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More HUMA financial trends
HUMA RevenueHUMA Net incomeHUMA Net marginHUMA Gross profitHUMA Gross marginHUMA Operating incomeHUMA Operating marginHUMA Operating cash flowHUMA Free cash flowHUMA Capital expendituresHUMA Return on equityHUMA Stock buybacksHUMA Dividends paidHUMA Total assetsHUMA Shareholders’ equityHUMA overview →